Evidence map›Paper›PMID 30298816›Full record

ArticleeLife2018

Spatiotemporal mosaic self-patterning of pluripotent stem cells using CRISPR interference.

Ashley Rg Libby, David A Joy, Po-Lin So, Mohammad A Mandegar, Jonathon M Muncie, Federico N Mendoza-Camacho, Valerie M Weaver, Bruce R Conklin, Todd C McDevitt

Open access · goldAbstract read
In one paragraph

Article in eLife, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ashley Rg LibbyGladstone Institute of Cardiovascular Disease, San Francisco, United States.ORCID 0000-0002-8139-8844
David A JoyGladstone Institute of Cardiovascular Disease, San Francisco, United States.
Po-Lin SoGladstone Institute of Cardiovascular Disease, San Francisco, United States.
Mohammad A MandegarGladstone Institute of Cardiovascular Disease, San Francisco, United States.
Jonathon M MuncieGraduate Program in Bioengineering, University of California Berkeley, University of California San Francisco, San Francisco, United States.
Federico N Mendoza-CamachoGladstone Institute of Cardiovascular Disease, San Francisco, United States.
Valerie M WeaverDepartment of Surgery, Center for Bioengineering and Tissue Regeneration, University of California, San Francisco, United States.
Bruce R ConklinGladstone Institute of Cardiovascular Disease, San Francisco, United States.
Todd C McDevittGladstone Institute of Cardiovascular Disease, San Francisco, United States.ORCID 0000-0002-8905-4931
Gladstone Institutes · USUniversity of California, San Francisco · US

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
Transcriptional Networks During Cardiac DifferentiationP01HL089707 · NHLBI · J. DAVID GLADSTONE INSTITUTES · PI CONKLIN, BRUCE R · 2008 to 2017
$20.4M
Induced Pluripotent Stem Cells in the Understanding and Treatment of Heart DiseasU01HL100406 · NHLBI · J. DAVID GLADSTONE INSTITUTES · PI BRUNEAU, BENOIT GAETAN, CONKLIN, BRUCE R · 2009 to 2015
$9.4M
PREDOCTORAL TRAINING IN DEVELOPMENTAL BIOLOGYT32HD007470 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Todd Nystul · 1994 to 2026
$7.7M
Therapeutic genome editing to treat Best diseaseR01EY028249 · NEI · J. DAVID GLADSTONE INSTITUTES · PI CONKLIN, BRUCE R · 2017 to 2021
$2.6M
Protein quality control, cardiomyopathy, cardiotoxicity and human isogenic iPSCsR01HL135358 · NHLBI · J. DAVID GLADSTONE INSTITUTES · PI CONKLIN, BRUCE R · 2017 to 2020
$2.0M
Identifying Therapeutic Targets for RNA Splicing-Related CardiomyopathyR01HL130533 · NHLBI · J. DAVID GLADSTONE INSTITUTES · PI CONKLIN, BRUCE R · 2016 to 2019
$1.8M
BD FACSAria II Flow CytometerS10RR028962 · NCRR · J. DAVID GLADSTONE INSTITUTES · PI CAVROIS, MARIELLE · 2011 to 2011
$544k
Genetically inducible cell sorting to interrogate human pluripotent stem cell lineage transitionsF31HL140907 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LIBBY, ASHLEY · 2018 to 2019
$71k
California Institute for Regenerative Medicine LAI-C1408015Emergent Behaviors of Integrated Cellular Systems NSF-CBET 0939511NCRR NIH HHS S10 RR028962NEI NIH HHS R01 EY028249NHLBI NIH HHS F31 HL140907NHLBI NIH HHS F31HL140907NHLBI NIH HHS P01 HL089707NHLBI NIH HHS R01 HL130533NHLBI NIH HHS R01 HL135358NHLBI NIH HHS U01 HL100406NIAID NIH HHS P30 AI027763NICHD NIH HHS T32 HD007470NIH HHS Center Core Grant, NIH P30 AI027763NIH HHS Instrumentation Grant, NIH S10 RR028962NIH HHS P01HL089707NIH HHS R01HL130533NIH HHS U01HL100406
6 · The paper itself

Abstract

Morphogenesis involves interactions of asymmetric cell populations to form complex multicellular patterns and structures comprised of distinct cell types. However, current methods to model morphogenic events lack control over cell-type co-emergence and offer little capability to selectively perturb specific cell subpopulations. Our

Indexed as

Antigens, CDCadherinsCell CommunicationCell DifferentiationCell LineageCRISPR-Cas SystemsGene Knockdown TechniquesHumansInduced Pluripotent Stem CellsMorphogenesisrho-Associated KinasesAntigens, CDCadherinsCDH1 protein, humanrho-Associated KinasesROCK1 protein, humanbio-engineeringdevelopmental biologyhumanmorphogenesispluripotent stem cellsregenerative medicinestem cells

Identifiers

PMID30298816
PMCPMC6177255
OpenAlexW2950381413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.